Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the current ...
Healthcare institutions are trying to drive productivity by increasing patient throughput while still maintaining a ...
Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its novel, next-generation Drug-Filled Stent (DFS).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam Reconstruction (WBR) technology.
CS Medical announced the release of their newest product designed to aid in the circle of care for transesophageal echo (TEE) probes.
April 19, 2016 — Toshiba America Medical Systems Inc.’s Aquilion Lightning computed tomography (CT) system was U.S. Food ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with average cholesterol and blood pressure levels who were considered to be at intermediate risk for heart disease, according to a new study.
April 20, 2016 — A competition that used technology to encourage and track physical activity was effective at helping ...
April 20, 2016 — Boston Scientific Corp. announced a U.S. Food and Drug Administration (FDA) Class 1 recall of the Fetch ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
In the first large randomized trial to directly compare two approaches to preventing atrial fibrillation following heart surgery, controlling heart rate and controlling heart rhythm performed equally well.
The continuation of positive clinical trial data for transcatheter aortic valve repair (TAVR), showing it is equal to or ...
In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction, the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing “gold standard” therapy angiotensin-converting enzyme (ACE) inhibitor enalapril.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
St. Jude Medical Inc. announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe.
A large randomized controlled trial of ischemic postconditioning in patients who had experienced ST-segment elevation myocardial infarction (STEMI) failed to show the procedure significantly reduces death from any cause or hospitalization for heart failure.
April 19, 2016 — Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients ...